Filing Details

Accession Number:
0001567619-22-017697
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-21 18:06:09
Reporting Period:
2022-09-19
Accepted Time:
2022-09-21 18:06:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882361 Aptose Biosciences Inc. APTO Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650476 Fletcher Payne C/O Aptose Biosciences Inc.
251 Consumers Road, Suite 1105
Toronto A6 M2J 4R3
Sr Vp & Chief Fin. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2022-09-19 10,000 $0.68 10,000 No 4 P Indirect Fletcher Payne 2019 Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Fletcher Payne 2019 Trust